Jan 29 (Reuters) - Agomab Therapeutics is targeting a valuation of up to $828.5 million in its initial public offering (IPO) ...

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of ...

Despite rising medicine expenditures driven by expensive innovative therapies, the financial burden on patients in Belgium ...

A Belgian court will hold a hearing Tuesday on whether a former senior diplomat should go on trial over the 1961 killing of ...

United's goalkeeper has brought composure and technical excellence to one of the most scrutinised positions in English ...

BIRMINGHAM, England (AP) — Premier League title contender Aston Villa will be without Belgium midfielder Youri Tielemans for ...

LONDON (AP) — Here’s the state of play after the conclusion of the first stage of the Champions League: Arsenal, Bayern ...

Follow all the latest European Futsal Championship 2026 news from the official UEFA.com site. Includes latest news stories, ...

Newcastle United scouts are reportedly keeping a close eye on Club Brugge defender Joaquin Seys. Manager Eddie Howe wants to ...

Hey dog lovers, welcome back to the channel! Today, we're tackling a question that sparks heated debates among canine ...

Scientists in Belgium—that celebrated bastion of ancient beer culture—are harnessing genetic breakthroughs and machine ...

His explicit goal of ‘creating superhumans’ places him at the center of a debate that usually involves seasoned scientists ...